Clinical Study to Assess the Influence of a Saw Palmetto Preparation in Patients With Benign Prostatic Hyperplasia (BPH) and Sexual Dysfunctions
Launched by A. VOGEL AG · Nov 25, 2009
Trial Information
Current as of July 25, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Patients with BPH and sexual dysfunctions (erectile dysfunction or decrease in libido)
- • IPSS \> 4
- • BSFI, sexual drive questions \< 5
- Exclusion Criteria:
- • Lack of libido which is due to a psychic disease or a depressive mood -Excessivly strong lack of libido in the judgement of the investigator within the last two months
- • Patients with severe vascular disorders (microangiopathies)
- • Patients with known neuropathies
- • Severe diabetes mellitus
- • Patients with hypertension who are for less than two months on a stable antihypertensive medication
- • Known bad compliance of the patient
About A. Vogel Ag
A. Vogel AG is a leading Swiss company specializing in the development and production of high-quality herbal remedies and natural health products. With a commitment to sustainability and research-backed efficacy, A. Vogel AG integrates traditional herbal knowledge with modern scientific principles to create innovative solutions for health and well-being. The company actively engages in clinical trials to validate the effectiveness of its products, ensuring that they meet rigorous safety and quality standards. Through its dedication to natural health, A. Vogel AG aims to empower individuals to take control of their health through nature-based solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chur, , Switzerland
Patients applied
Trial Officials
Eugen Riedi, MD
Principal Investigator
independent
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials